EA200501046A1 - Эсциталопрамгидробромид и способ его получения - Google Patents

Эсциталопрамгидробромид и способ его получения

Info

Publication number
EA200501046A1
EA200501046A1 EA200501046A EA200501046A EA200501046A1 EA 200501046 A1 EA200501046 A1 EA 200501046A1 EA 200501046 A EA200501046 A EA 200501046A EA 200501046 A EA200501046 A EA 200501046A EA 200501046 A1 EA200501046 A1 EA 200501046A1
Authority
EA
Eurasian Patent Office
Prior art keywords
escitalopramhydrobromid
way
escitalopram
citalopram
hydrobromide
Prior art date
Application number
EA200501046A
Other languages
English (en)
Other versions
EA013116B1 (ru
Inventor
Лоренс Мартел
Роберт Дансер
Ханс Петерсен
Петер Эллегор
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200501046(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200501046A1 publication Critical patent/EA200501046A1/ru
Publication of EA013116B1 publication Critical patent/EA013116B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Эсциталопрам (S-циталопрам) в форме гидробромида, способы получения указанного соединения и содержащие эсциталопрам фармацевтические композиции.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200501046A 2002-12-23 2003-12-18 Эсциталопрамгидробромид, его применение и фармкомпозиция EA013116B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202005 2002-12-23
PCT/DK2003/000902 WO2004056791A1 (en) 2002-12-23 2003-12-18 Escitalopram hydrobromide and a method for the preparation thereof

Publications (2)

Publication Number Publication Date
EA200501046A1 true EA200501046A1 (ru) 2005-12-29
EA013116B1 EA013116B1 (ru) 2010-02-26

Family

ID=32668635

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501046A EA013116B1 (ru) 2002-12-23 2003-12-18 Эсциталопрамгидробромид, его применение и фармкомпозиция

Country Status (33)

Country Link
US (1) US20040167209A1 (ru)
EP (1) EP1578738B1 (ru)
JP (2) JP4658613B2 (ru)
KR (1) KR20050086933A (ru)
CN (1) CN100349885C (ru)
AR (1) AR042652A1 (ru)
AT (1) ATE388947T1 (ru)
AU (1) AU2003287919B2 (ru)
BR (1) BR0317623A (ru)
CA (1) CA2511142A1 (ru)
CY (1) CY1107451T1 (ru)
DE (1) DE60319739T2 (ru)
DK (1) DK1578738T3 (ru)
EA (1) EA013116B1 (ru)
EG (1) EG24729A (ru)
ES (1) ES2298595T3 (ru)
HK (1) HK1087708A1 (ru)
IL (1) IL169125A0 (ru)
IS (1) IS2654B (ru)
ME (1) MEP5808A (ru)
MX (1) MXPA05005772A (ru)
MY (1) MY135468A (ru)
NO (1) NO20053595L (ru)
NZ (1) NZ540281A (ru)
PE (1) PE20040924A1 (ru)
PL (1) PL378275A1 (ru)
PT (1) PT1578738E (ru)
RS (1) RS51092B (ru)
TW (1) TW200501943A (ru)
UA (1) UA80170C2 (ru)
UY (1) UY28148A1 (ru)
WO (1) WO2004056791A1 (ru)
ZA (1) ZA200504109B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
MXPA05005772A (es) * 2002-12-23 2005-08-16 Lundbeck & Co As H Bromhidrato de escitalopram y un metodo para su preparacion.
WO2005084643A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EA200801081A1 (ru) * 2005-10-14 2008-10-30 Х. Лундбекк А/С Способы лечения расстройств центральной нервной системы комбинацией малых доз эсциталопрама и бупропиона
US20070112075A1 (en) * 2005-10-14 2007-05-17 Forest Laboratories, Inc. Stable pharmaceutical formulations containing escitalopram and bupropion
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
TWI399375B (zh) * 2006-07-11 2013-06-21 Mitsubishi Tanabe Pharma Corp 嗎啉化合物之鹽
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FR3006594A1 (fr) * 2013-06-11 2014-12-12 Sorin Crm Sas Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) * 2017-06-05 2022-12-06 上海奥博生物医药股份有限公司 一种艾司西酞普兰双羟萘酸盐新的制备方法
JP7237269B2 (ja) * 2017-10-09 2023-03-13 ４２８ ファーマ ビーブイ． エスシタロプラムの新しい塩および固体形態
US20240100012A1 (en) 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34712A (en) * 1862-03-18 James h
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
WO2000023431A1 (en) * 1998-10-20 2000-04-27 H. Lundbeck A/S Method for the preparation of citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
PT1298124E (pt) * 1999-10-25 2007-05-31 Lundbeck & Co As H Método para a preparação de citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
JP2002020379A (ja) * 2000-05-02 2002-01-23 Sumika Fine Chemicals Co Ltd シタロプラム臭化水素酸塩の結晶およびその結晶化方法
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
EP1339817B1 (de) * 2000-12-04 2007-06-13 Westfalia Separator AG Verfahren zur herstellung von fettsaüreestern
CA2445843A1 (en) * 2001-05-01 2002-11-07 H. Lundbeck A/S The use of enantiomeric pure escitalopram
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
MXPA05005772A (es) * 2002-12-23 2005-08-16 Lundbeck & Co As H Bromhidrato de escitalopram y un metodo para su preparacion.
US20050174782A1 (en) * 2003-03-25 2005-08-11 Chapman Leonard T. Flashlight

Also Published As

Publication number Publication date
CN1726202A (zh) 2006-01-25
EP1578738B1 (en) 2008-03-12
DK1578738T3 (da) 2008-06-30
UY28148A1 (es) 2004-09-30
CA2511142A1 (en) 2004-07-08
MY135468A (en) 2008-04-30
UA80170C2 (en) 2007-08-27
ES2298595T3 (es) 2008-05-16
AU2003287919A1 (en) 2004-07-14
JP2006514952A (ja) 2006-05-18
DE60319739T2 (de) 2008-07-17
MXPA05005772A (es) 2005-08-16
MEP5808A (xx) 2010-02-10
AR042652A1 (es) 2005-06-29
IS7848A (is) 2005-05-17
BR0317623A (pt) 2005-11-29
JP2011037893A (ja) 2011-02-24
RS51092B (sr) 2010-10-31
PE20040924A1 (es) 2004-12-11
NO20053595L (no) 2005-09-05
IS2654B (is) 2010-08-15
AU2003287919B2 (en) 2009-11-12
PL378275A1 (pl) 2006-03-20
WO2004056791A1 (en) 2004-07-08
EP1578738A1 (en) 2005-09-28
EG24729A (en) 2010-06-21
TW200501943A (en) 2005-01-16
KR20050086933A (ko) 2005-08-30
ATE388947T1 (de) 2008-03-15
HK1087708A1 (en) 2006-10-20
ZA200504109B (en) 2006-08-30
IL169125A0 (en) 2009-02-11
NZ540281A (en) 2008-07-31
CN100349885C (zh) 2007-11-21
DE60319739D1 (de) 2008-04-24
US20040167209A1 (en) 2004-08-26
CY1107451T1 (el) 2012-12-19
RS20050487A (en) 2007-06-04
EA013116B1 (ru) 2010-02-26
JP4658613B2 (ja) 2011-03-23
PT1578738E (pt) 2008-04-11

Similar Documents

Publication Publication Date Title
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
EA200501046A1 (ru) Эсциталопрамгидробромид и способ его получения
EA200501250A1 (ru) Композиция, содержащая смесь активных начал, и способ ее получения
BRPI0414599A (pt) pirrol-indóis substituìdos
EA200400971A1 (ru) Фторзамещенные циклоалканоиндолы, композиции, содержащие такие соединения, и способы лечения
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
EA200400241A1 (ru) Направленные к мишени мультимерные контрастные вещества, основанные на пептидах
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
DK1311482T3 (da) Ikke-imidazolaryloxypiperidiner som H3-receptorligander
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
NO20091976L (no) Nye forbindelser
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
EA200300593A1 (ru) Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора
EA200200912A1 (ru) Новые производные индолин-2-она, их получение и их применение в качестве лигандов рецепторов окситоцина
EA200100012A1 (ru) Мостиковые инденопирролокарбазолы
EA200300450A1 (ru) Фармацевтические растворы соединений модафинила
EA200400487A1 (ru) Фармацевтическая композиция длительного высвобождения, содержащая метформин
EA200300988A1 (ru) Производные фенил-гетероциклильных эфиров в качестве ингибиторов обратного захвата серотонина
EA200300066A1 (ru) Производные аминоалкоксибензоил-бензофурана или бензотиофена, способ их получения и содержащие их композиции
EA200101234A1 (ru) Новые производные аминотиазола, их получение и содержащие их фармацевтические композиции
EA200500486A1 (ru) Новые фармацевтические составы модафинила
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
EA200401067A1 (ru) Раствор ибупрофена для капсул с твердыми оболочками
EA199800034A1 (ru) Способ получения n-монозамещенных и n,n'-дизамещенных асимметричных циклических мочевин

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU